secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nkarta, Inc. (NKTX)
CIK:        0001787400
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0000950170-24-038037
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nkarta raises ~$225.2M in underwritten offering of stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering of 21,010,000 shares at $10.00 and pre-funded warrants for 3,000,031 shares at $9.9999.
- Net proceeds of ~$225.2M after underwriting discounts and estimated expenses.
- Proceeds to fund NKX019 clinical development and internal manufacturing buildout.
- Pre-funded warrants exercisable immediately at $0.0001 per share, with 19.99% ownership cap.
- Underwriting agreement with Leerink Partners and Cowen and Company, LLC, dated March 25, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787400/000095017024038037/0000950170-24-038037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787400/000095017024038037/nktx-20240325.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-038037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer